Management of hereditary angioedema attacks by patients on long-term prophylaxis versus on-demand therapy only

Background: Despite the use of long-term prophylaxis (LTP) for hereditary angioedema (HAE), the risk of having an attack remains and patients with HAE and on LTP may still experience attacks that can be life threatening. However, the behavioralpatterns and perspectives surrounding HAE attack managem...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Allergy and asthma proceedings 2025-01, Vol.46 (1), p.32-37
Hauptverfasser: Lumry, William R, Grumach, Anete S, Betschel, Stephen D, Radojicic, Cristine, van Kooten, Sally, Heckmann, Markus, Danese, Sherry, Malloy, Neil, Goga, Ledia, Guilarte, Mar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 37
container_issue 1
container_start_page 32
container_title Allergy and asthma proceedings
container_volume 46
creator Lumry, William R
Grumach, Anete S
Betschel, Stephen D
Radojicic, Cristine
van Kooten, Sally
Heckmann, Markus
Danese, Sherry
Malloy, Neil
Goga, Ledia
Guilarte, Mar
description Background: Despite the use of long-term prophylaxis (LTP) for hereditary angioedema (HAE), the risk of having an attack remains and patients with HAE and on LTP may still experience attacks that can be life threatening. However, the behavioralpatterns and perspectives surrounding HAE attack management by patients on LTP are not fully understood.Objective: This survey aimed to better understand and compare the behavioral patterns and perspectives, including attitudesand perceptions associated with on-demand treatment among patients on LTP versus those using on-demand therapy only.Methods: People living with HAE were recruited by the US Hereditary Angioedema Association to complete a 20-minute online survey between September 6 and October 19, 2022. Participants were stratified by treatment (50% using LTP [+ondemand therapy], 50% on-demand therapy only).Results: Respondents included 107 patients with HAE (mean age, 41 years [range, 16–83 years]). Patients using LTP reported treating a mean +/- standard deviation 84.8% +/- 23.8% of their HAE attacks compared with a mean +/- standard deviation75.6% +/- 27.5% for patients with on-demand only treatment. Similar percentages of patients on LTP versus patients on-demand only reported always carrying on-demand treatment when away from home (35% versus 38%) and modifying their daily lives to minimize the occurrence of HAE attacks, which included avoiding potential triggers (42.9% versus 45.5%).Conclusion: Although patients on LTP treat a higher percentage of their attacks compared with patients with on-demand only treatment, both groups reported similar behaviors in terms of carrying on-demand treatment when away from home and modifying their daily lives to minimize the occurrence of HAE attacks. These findings highlight the importance of understanding patient perspectives and behaviors in the management of HAE
doi_str_mv 10.2500/aap.2025.46.240096
format Article
fullrecord <record><control><sourceid>pubtec_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3132842932</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ingid>ocean/aap/10.2500/aap.2025.46.240096</ingid><sourcerecordid>ocean/aap/10.2500/aap.2025.46.240096</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3038-47c00cc76f3bce0df338f2eb0f06f15a42f5fda8209c4befc635830f2b41eb2f3</originalsourceid><addsrcrecordid>eNp9kktv1TAQhSMEoqXwB1ggS2zY5DJ-1pHYoIoCUhEbWFuOM05TEifETtt0yS_H4V5AQiorv875xpozRfGcwo5JgNfWTjsGTO6E2jEBUKkHxTGVvCoVB_Ew70HrUgrKjoonMV4BUMGVelwc8UpqJbU-LsInG2yLA4ZERk8uccamS3ZeiQ1tN2KDgyU2Jeu-RVKvZLKpy9pIxkD6MbRlwnkg0zxOl2tvb7tIrnGOy_Zebt7QkJShdlrzTb8-LR5520d8dlhPiq_n776cfSgvPr__ePb2onQcuC7FqQNw7lR5XjuExnOuPcMaPChPpRXMS99YzaByokbvFJeag2e1oFgzz0-KV3tu_tn3BWMyQxcd9r0NOC7RcMqZFqziLEtf_iO9Gpc55N9llRSCAlUiq9he5eYxxhm9meZuyH0yFMyWhslpmC0NI5TZp5FNLw7opR6w-WP53f4seLMXdKHNXbV_S48ObfjF_C__xz32zh0I2whsE2AC3kwzXnd4EzcUy0QmzGh9mijNFbZTxgtKmTKgQJoGvV36ZPI0mPbuPhP_CcvIxv8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3154410164</pqid></control><display><type>article</type><title>Management of hereditary angioedema attacks by patients on long-term prophylaxis versus on-demand therapy only</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Lumry, William R ; Grumach, Anete S ; Betschel, Stephen D ; Radojicic, Cristine ; van Kooten, Sally ; Heckmann, Markus ; Danese, Sherry ; Malloy, Neil ; Goga, Ledia ; Guilarte, Mar</creator><creatorcontrib>Lumry, William R ; Grumach, Anete S ; Betschel, Stephen D ; Radojicic, Cristine ; van Kooten, Sally ; Heckmann, Markus ; Danese, Sherry ; Malloy, Neil ; Goga, Ledia ; Guilarte, Mar</creatorcontrib><description>Background: Despite the use of long-term prophylaxis (LTP) for hereditary angioedema (HAE), the risk of having an attack remains and patients with HAE and on LTP may still experience attacks that can be life threatening. However, the behavioralpatterns and perspectives surrounding HAE attack management by patients on LTP are not fully understood.Objective: This survey aimed to better understand and compare the behavioral patterns and perspectives, including attitudesand perceptions associated with on-demand treatment among patients on LTP versus those using on-demand therapy only.Methods: People living with HAE were recruited by the US Hereditary Angioedema Association to complete a 20-minute online survey between September 6 and October 19, 2022. Participants were stratified by treatment (50% using LTP [+ondemand therapy], 50% on-demand therapy only).Results: Respondents included 107 patients with HAE (mean age, 41 years [range, 16–83 years]). Patients using LTP reported treating a mean +/- standard deviation 84.8% +/- 23.8% of their HAE attacks compared with a mean +/- standard deviation75.6% +/- 27.5% for patients with on-demand only treatment. Similar percentages of patients on LTP versus patients on-demand only reported always carrying on-demand treatment when away from home (35% versus 38%) and modifying their daily lives to minimize the occurrence of HAE attacks, which included avoiding potential triggers (42.9% versus 45.5%).Conclusion: Although patients on LTP treat a higher percentage of their attacks compared with patients with on-demand only treatment, both groups reported similar behaviors in terms of carrying on-demand treatment when away from home and modifying their daily lives to minimize the occurrence of HAE attacks. These findings highlight the importance of understanding patient perspectives and behaviors in the management of HAE</description><identifier>ISSN: 1088-5412</identifier><identifier>ISSN: 1539-6304</identifier><identifier>EISSN: 1539-6304</identifier><identifier>DOI: 10.2500/aap.2025.46.240096</identifier><identifier>PMID: 39586588</identifier><language>eng</language><publisher>United States: OceanSide Publications, Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Angioedema ; Angioedemas, Hereditary - drug therapy ; Angioedemas, Hereditary - prevention &amp; control ; Behavior ; Complement C1 Inhibitor Protein - administration &amp; dosage ; Complement C1 Inhibitor Protein - therapeutic use ; Disease Management ; Disease prevention ; Female ; Humans ; Long-term potentiation ; Male ; Middle Aged ; Prophylaxis ; Standard deviation ; Surveys ; Surveys and Questionnaires ; Therapy ; Young Adult</subject><ispartof>Allergy and asthma proceedings, 2025-01, Vol.46 (1), p.32-37</ispartof><rights>Copyright OceanSide Publications 2025</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3038-47c00cc76f3bce0df338f2eb0f06f15a42f5fda8209c4befc635830f2b41eb2f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39586588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lumry, William R</creatorcontrib><creatorcontrib>Grumach, Anete S</creatorcontrib><creatorcontrib>Betschel, Stephen D</creatorcontrib><creatorcontrib>Radojicic, Cristine</creatorcontrib><creatorcontrib>van Kooten, Sally</creatorcontrib><creatorcontrib>Heckmann, Markus</creatorcontrib><creatorcontrib>Danese, Sherry</creatorcontrib><creatorcontrib>Malloy, Neil</creatorcontrib><creatorcontrib>Goga, Ledia</creatorcontrib><creatorcontrib>Guilarte, Mar</creatorcontrib><title>Management of hereditary angioedema attacks by patients on long-term prophylaxis versus on-demand therapy only</title><title>Allergy and asthma proceedings</title><addtitle>Allergy Asthma Proc</addtitle><description>Background: Despite the use of long-term prophylaxis (LTP) for hereditary angioedema (HAE), the risk of having an attack remains and patients with HAE and on LTP may still experience attacks that can be life threatening. However, the behavioralpatterns and perspectives surrounding HAE attack management by patients on LTP are not fully understood.Objective: This survey aimed to better understand and compare the behavioral patterns and perspectives, including attitudesand perceptions associated with on-demand treatment among patients on LTP versus those using on-demand therapy only.Methods: People living with HAE were recruited by the US Hereditary Angioedema Association to complete a 20-minute online survey between September 6 and October 19, 2022. Participants were stratified by treatment (50% using LTP [+ondemand therapy], 50% on-demand therapy only).Results: Respondents included 107 patients with HAE (mean age, 41 years [range, 16–83 years]). Patients using LTP reported treating a mean +/- standard deviation 84.8% +/- 23.8% of their HAE attacks compared with a mean +/- standard deviation75.6% +/- 27.5% for patients with on-demand only treatment. Similar percentages of patients on LTP versus patients on-demand only reported always carrying on-demand treatment when away from home (35% versus 38%) and modifying their daily lives to minimize the occurrence of HAE attacks, which included avoiding potential triggers (42.9% versus 45.5%).Conclusion: Although patients on LTP treat a higher percentage of their attacks compared with patients with on-demand only treatment, both groups reported similar behaviors in terms of carrying on-demand treatment when away from home and modifying their daily lives to minimize the occurrence of HAE attacks. These findings highlight the importance of understanding patient perspectives and behaviors in the management of HAE</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angioedema</subject><subject>Angioedemas, Hereditary - drug therapy</subject><subject>Angioedemas, Hereditary - prevention &amp; control</subject><subject>Behavior</subject><subject>Complement C1 Inhibitor Protein - administration &amp; dosage</subject><subject>Complement C1 Inhibitor Protein - therapeutic use</subject><subject>Disease Management</subject><subject>Disease prevention</subject><subject>Female</subject><subject>Humans</subject><subject>Long-term potentiation</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prophylaxis</subject><subject>Standard deviation</subject><subject>Surveys</subject><subject>Surveys and Questionnaires</subject><subject>Therapy</subject><subject>Young Adult</subject><issn>1088-5412</issn><issn>1539-6304</issn><issn>1539-6304</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kktv1TAQhSMEoqXwB1ggS2zY5DJ-1pHYoIoCUhEbWFuOM05TEifETtt0yS_H4V5AQiorv875xpozRfGcwo5JgNfWTjsGTO6E2jEBUKkHxTGVvCoVB_Ew70HrUgrKjoonMV4BUMGVelwc8UpqJbU-LsInG2yLA4ZERk8uccamS3ZeiQ1tN2KDgyU2Jeu-RVKvZLKpy9pIxkD6MbRlwnkg0zxOl2tvb7tIrnGOy_Zebt7QkJShdlrzTb8-LR5520d8dlhPiq_n776cfSgvPr__ePb2onQcuC7FqQNw7lR5XjuExnOuPcMaPChPpRXMS99YzaByokbvFJeag2e1oFgzz0-KV3tu_tn3BWMyQxcd9r0NOC7RcMqZFqziLEtf_iO9Gpc55N9llRSCAlUiq9he5eYxxhm9meZuyH0yFMyWhslpmC0NI5TZp5FNLw7opR6w-WP53f4seLMXdKHNXbV_S48ObfjF_C__xz32zh0I2whsE2AC3kwzXnd4EzcUy0QmzGh9mijNFbZTxgtKmTKgQJoGvV36ZPI0mPbuPhP_CcvIxv8</recordid><startdate>20250101</startdate><enddate>20250101</enddate><creator>Lumry, William R</creator><creator>Grumach, Anete S</creator><creator>Betschel, Stephen D</creator><creator>Radojicic, Cristine</creator><creator>van Kooten, Sally</creator><creator>Heckmann, Markus</creator><creator>Danese, Sherry</creator><creator>Malloy, Neil</creator><creator>Goga, Ledia</creator><creator>Guilarte, Mar</creator><general>OceanSide Publications, Inc</general><general>OceanSide Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20250101</creationdate><title>Management of hereditary angioedema attacks by patients on long-term prophylaxis versus on-demand therapy only</title><author>Lumry, William R ; Grumach, Anete S ; Betschel, Stephen D ; Radojicic, Cristine ; van Kooten, Sally ; Heckmann, Markus ; Danese, Sherry ; Malloy, Neil ; Goga, Ledia ; Guilarte, Mar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3038-47c00cc76f3bce0df338f2eb0f06f15a42f5fda8209c4befc635830f2b41eb2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angioedema</topic><topic>Angioedemas, Hereditary - drug therapy</topic><topic>Angioedemas, Hereditary - prevention &amp; control</topic><topic>Behavior</topic><topic>Complement C1 Inhibitor Protein - administration &amp; dosage</topic><topic>Complement C1 Inhibitor Protein - therapeutic use</topic><topic>Disease Management</topic><topic>Disease prevention</topic><topic>Female</topic><topic>Humans</topic><topic>Long-term potentiation</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prophylaxis</topic><topic>Standard deviation</topic><topic>Surveys</topic><topic>Surveys and Questionnaires</topic><topic>Therapy</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lumry, William R</creatorcontrib><creatorcontrib>Grumach, Anete S</creatorcontrib><creatorcontrib>Betschel, Stephen D</creatorcontrib><creatorcontrib>Radojicic, Cristine</creatorcontrib><creatorcontrib>van Kooten, Sally</creatorcontrib><creatorcontrib>Heckmann, Markus</creatorcontrib><creatorcontrib>Danese, Sherry</creatorcontrib><creatorcontrib>Malloy, Neil</creatorcontrib><creatorcontrib>Goga, Ledia</creatorcontrib><creatorcontrib>Guilarte, Mar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Allergy and asthma proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lumry, William R</au><au>Grumach, Anete S</au><au>Betschel, Stephen D</au><au>Radojicic, Cristine</au><au>van Kooten, Sally</au><au>Heckmann, Markus</au><au>Danese, Sherry</au><au>Malloy, Neil</au><au>Goga, Ledia</au><au>Guilarte, Mar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of hereditary angioedema attacks by patients on long-term prophylaxis versus on-demand therapy only</atitle><jtitle>Allergy and asthma proceedings</jtitle><addtitle>Allergy Asthma Proc</addtitle><date>2025-01-01</date><risdate>2025</risdate><volume>46</volume><issue>1</issue><spage>32</spage><epage>37</epage><pages>32-37</pages><issn>1088-5412</issn><issn>1539-6304</issn><eissn>1539-6304</eissn><abstract>Background: Despite the use of long-term prophylaxis (LTP) for hereditary angioedema (HAE), the risk of having an attack remains and patients with HAE and on LTP may still experience attacks that can be life threatening. However, the behavioralpatterns and perspectives surrounding HAE attack management by patients on LTP are not fully understood.Objective: This survey aimed to better understand and compare the behavioral patterns and perspectives, including attitudesand perceptions associated with on-demand treatment among patients on LTP versus those using on-demand therapy only.Methods: People living with HAE were recruited by the US Hereditary Angioedema Association to complete a 20-minute online survey between September 6 and October 19, 2022. Participants were stratified by treatment (50% using LTP [+ondemand therapy], 50% on-demand therapy only).Results: Respondents included 107 patients with HAE (mean age, 41 years [range, 16–83 years]). Patients using LTP reported treating a mean +/- standard deviation 84.8% +/- 23.8% of their HAE attacks compared with a mean +/- standard deviation75.6% +/- 27.5% for patients with on-demand only treatment. Similar percentages of patients on LTP versus patients on-demand only reported always carrying on-demand treatment when away from home (35% versus 38%) and modifying their daily lives to minimize the occurrence of HAE attacks, which included avoiding potential triggers (42.9% versus 45.5%).Conclusion: Although patients on LTP treat a higher percentage of their attacks compared with patients with on-demand only treatment, both groups reported similar behaviors in terms of carrying on-demand treatment when away from home and modifying their daily lives to minimize the occurrence of HAE attacks. These findings highlight the importance of understanding patient perspectives and behaviors in the management of HAE</abstract><cop>United States</cop><pub>OceanSide Publications, Inc</pub><pmid>39586588</pmid><doi>10.2500/aap.2025.46.240096</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1088-5412
ispartof Allergy and asthma proceedings, 2025-01, Vol.46 (1), p.32-37
issn 1088-5412
1539-6304
1539-6304
language eng
recordid cdi_proquest_miscellaneous_3132842932
source MEDLINE; Alma/SFX Local Collection
subjects Adolescent
Adult
Aged
Aged, 80 and over
Angioedema
Angioedemas, Hereditary - drug therapy
Angioedemas, Hereditary - prevention & control
Behavior
Complement C1 Inhibitor Protein - administration & dosage
Complement C1 Inhibitor Protein - therapeutic use
Disease Management
Disease prevention
Female
Humans
Long-term potentiation
Male
Middle Aged
Prophylaxis
Standard deviation
Surveys
Surveys and Questionnaires
Therapy
Young Adult
title Management of hereditary angioedema attacks by patients on long-term prophylaxis versus on-demand therapy only
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T19%3A01%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubtec_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20hereditary%20angioedema%20attacks%20by%20patients%20on%20long-term%20prophylaxis%20versus%20on-demand%20therapy%20only&rft.jtitle=Allergy%20and%20asthma%20proceedings&rft.au=Lumry,%20William%20R&rft.date=2025-01-01&rft.volume=46&rft.issue=1&rft.spage=32&rft.epage=37&rft.pages=32-37&rft.issn=1088-5412&rft.eissn=1539-6304&rft_id=info:doi/10.2500/aap.2025.46.240096&rft_dat=%3Cpubtec_proqu%3Eocean/aap/10.2500/aap.2025.46.240096%3C/pubtec_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3154410164&rft_id=info:pmid/39586588&rft_ingid=ocean/aap/10.2500/aap.2025.46.240096&rfr_iscdi=true